Business Description
Acro Biomedical Co Ltd
NAICS : 551112
SIC : 6719
ISIN : US0048921052
Total Employee Number:
1Description
Acro Biomedical Co Ltd is a shell company.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.29 | |||||
Equity-to-Asset | -106.75 | |||||
Debt-to-Equity | -0.03 | |||||
Debt-to-EBITDA | -0.11 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 80.4 | |||||
3-Year FCF Growth Rate | -14.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
9-Day RSI | 100 | |||||
14-Day RSI | 100 | |||||
6-1 Month Momentum % | 3614.29 | |||||
12-1 Month Momentum % | 3614.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 0.99 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -675 | |||||
ROIC % | -468.04 | |||||
3-Year ROIIC % | -3105.93 | |||||
ROC (Joel Greenblatt) % | -604.92 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 2 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -12.8 | |||||
EV-to-EBITDA | -12.8 | |||||
EV-to-FCF | -7.06 | |||||
Earnings Yield (Greenblatt) % | -7.81 | |||||
FCF Yield % | -14.29 |
GF Valueâ„¢
Acro Biomedical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Acro Biomedical Co Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-10 | In 134 days | ||
| General meeting for 2025 | 2026-06-30 | In 1 day | ||
| First quarter earnings results for 2026 | 2026-05-05 | 0.03 (+0.00%) | ||
| Annual report for 2025 | 2026-02-11 | 0.02 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-10 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-05 | 0.00 (+0.00%) | ||
| Annual report for 2024 | 2025-07-24 | 0.00 (+0.00%) | ||
| First quarter earnings results for 2025 | 2025-07-24 | 0.00 (+0.00%) | ||
| Second quarter earnings results for 2024 | 2025-07-23 | 0.00 (+0.00%) | ||
| Third quarter earnings results for 2024 | 2025-07-23 | 0.00 (+0.00%) |
Show
Entries
Guru Commentaries on OTCPK:ACBM
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Acro Biomedical Co Ltd
No articles.